The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Rapid Response Innovation Awards, 2007Ghrelin Protects Nigral Dopamine Neurons
Objective/Rationale:
Our preliminary findings indicate that the gut hormone, ghrelin, has a major impact on the functionality and protection of nigrostriatal dopamine neurons. We, therefore, will test... -
Rapid Response Innovation Awards, 2007Feasibility of Intranasal Delivery of GDNF for Parkinson's Disease
Objective/Rationale:
Glial cell line-derived neurotrophic factor (GDNF) is a small protein that potently promotes the survival of many types of neurons. The therapeutic potential of GDNF for Parkinson... -
Rapid Response Innovation Awards, 2007Virtual Reality to Reduce Fall Risk in Patients with Parkinson’s Disease
Objective/Rationale:
Virtual Reality (VR) allows for training in complex environments, while motivating subjects to perform numerous repetitions of the training tasks under well-controlled conditions... -
LEAPS, 2007Discovery of mGluR4 Potentiators for Symptoms & Side Effects and Disease-Modifying Treatment of PD
Objective/Rationale:
Surgical approaches to treatment of Parkinson’s disease using deep brain stimulation and corrective lesions provide valuable insights into novel approaches for treatment of this... -
Biomarkers, 2007Prospective Validation of Risk Markers for the Development of Parkinson’s Disease
Objective/Rationale:
The development of disease-course modifying or neuroprotective treatments is still an unmet therapeutical need in Parkinson’s disease. Treatment will likely work best if initiated... -
Biomarkers, 2007A Gene Expression Signature for the Early Detection of Parkinson Disease
Objective/Rationale:
The primary goal for the project is to develop a highly accurate and reproducible gene expression signature in blood to discriminate Parkinson disease both from other closely...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.